192. Plast Reconstr Surg. 2018 Apr;141(4):586e-599e. doi:10.1097/PRS.0000000000004262.How to Diagnose and Treat Breast Implant-Associated Anaplastic Large CellLymphoma.Clemens MW(1), Brody GS, Mahabir RC, Miranda RN.Author information: (1)Houston, Texas; Los Angeles, Calif.; and Scottsdale, Ariz. From theDepartments of Plastic Surgery and Hematopathology, M. D. Anderson Cancer Center;the Department of Plastic Surgery, Keck School of Medicine, University ofSouthern California; and the Department of Plastic Surgery, Mayo Clinic.LEARNING OBJECTIVES: After reading this article, the participant should be ableto: 1. Describe the diagnostic criteria for breast implant-associated (BIA)anaplastic large cell lymphoma (ALCL). 2. Appropriately evaluate a patient withsuspected BIA-ALCL, including appropriate imaging, laboratory tests, andpathologic evaluation. 3. Understand the operative treatment of BIA-ALCL, andindications for systemic chemotherapy and/or radiation therapy in advanceddisease. 4. Understand treatment outcomes and prognosis based on stage ofdisease.SUMMARY: The goal of this continuing medical education module is to present theassessment of a patient with suspected breast implant-associated anaplastic largecell lymphoma, the evaluation and diagnosis, the preoperative oncologic workup,the formation and execution of a surgical treatment plan, and the inclusion ofadjunct treatments when indicated. In addition, staging and disease progressionfor treatment of breast implant-associated anaplastic large cell lymphoma arediscussed.DOI: 10.1097/PRS.0000000000004262 PMID: 29595739 